首页 | 本学科首页   官方微博 | 高级检索  
检索        

膀胱扩张术治疗氯胺酮相关性膀胱挛缩的疗效观察
引用本文:吴忠亮,陈征,张俊夫,徐晓龙,江东根,林佳钦,刘宏,狄金明,刘肖瑛.膀胱扩张术治疗氯胺酮相关性膀胱挛缩的疗效观察[J].中华腔镜泌尿外科杂志(电子版),2018,12(1):43-46.
作者姓名:吴忠亮  陈征  张俊夫  徐晓龙  江东根  林佳钦  刘宏  狄金明  刘肖瑛
作者单位:1. 437400 湖北,通城县人民医院泌尿外科 2. 510630 广州,中山大学附属第三医院泌尿外科 3. 523320 广东,东莞市第三人民医院泌尿外科 4. 523110 广东,东莞市东华医院泌尿外科 5. 441900 广东,东莞市长安医院泌尿外科 6. 523080 广东,东莞康华医院检验科
基金项目:广州市科技计划项目(201709010038); 国家自然科学基金面上项目(81772752); 广东省科技计划项目(2017A020215122)
摘    要:目的探讨透明质酸钠平衡液膀胱扩张术治疗氯胺酮相关性膀胱挛缩的方法和疗效。 方法2010年07月至2016年02月6家医院共收治滥用氯胺酮所致膀胱挛缩患者18例,男15例,女3例。患者戒断吸食氯胺酮,灌注0.09%透明质酸钠平衡液扩张膀胱,每周1次共3次,首次灌注2倍于术前膀胱容量的平衡液,随后灌注量每次递增100 ml。记录术前及3次扩张术后3、12个月时患者盆腔疼痛及尿频评分(PUF)、O'Leary-SantIC症状评分(ICSI)及问题评分(ICPI)、生活质量评分(QOL)和膀胱容量情况。 结果18例患者均完成3次膀胱扩张术,术中无大出血、膀胱破裂等严重并发症。术后2例失访,2例8个月后复吸,14例完成最少12个月随访。该14例患者扩张术前及术后3、12个月时平均PUF分别为(20.4±3.6)、(11.5±3.1)和(13.2±3.3)分;ICSI分别为(13.6±2.8)、(7.7±2.3)和(8.2±2.5)分;ICPI分别为(10.6±2.6)、(7.3±2.1)和(7.7±2.5)分;QOL分别为(6.0±0)、(2.1±0.5)和(2.7±0.8)分;膀胱容量分别为(83±27)ml、(234±56)ml和(228±52)ml,所有指标术后与术前比较差异均有统计学意义(P<0.05)。 结论透明质酸钠平衡液膀胱扩张术治疗氯胺酮相关性膀胱挛缩安全有效,手术操作简单,耐受性好。

关 键 词:氯胺酮  膀胱挛缩  膀胱扩张术  透明质酸钠  
收稿时间:2017-02-22

Cystectasia treatment of ketamine-associated urocystic contracture
Authors:Zhongliang Wu  Zheng Chen  Junfu Zhang  Xiaolong Xu  Donggen Jiang  Jiaqin Lin  Hong Liu  Jinming Di  Xiaoying Liu
Abstract:ObjectiveTo study the methods and efficiency of cystectasia in the treatment of ketamine-associated urocystic contracture. MethodsEighteen cases including 15 males and 3 females from 6 hospitals with ketamine-associated urocystic contracture from 2010 July to 2016 February were selected and analyzed. All patients were with drawal from ketamine and treated by weekly cystectasia with 0.09% sodium hyaluronate balance solution 3 times. Two times the preoperative bladder capacity balance solution was instilled in the cystoscope under direct vision for the first time, followed by an increase of 100 ml each time through urinary catheter. The Pelvic Pain and Urgency/Frequency symptom score (PUF), O'Leary-Sant IC Symptom Index (ICSI) and IC Problem Index (ICPI), QOL score and bladder capacity were recorded before the surgery, and during three and twelve months follow-up after the third expansion. ResultsAll 18 patients were treated by cystectasia 3 times without significant complications such as intraoperative bleeding and bladder rupture. Two cases were lost after surgery. Two cases took ketamine again after 8 months. Fourteen cases were followed up at least 12 months. The mean PUF before the surgery, and three and twelve months follow-up after the third expansion were (20.4±3.6), (11.5±3.1) and (13.2±3.3) respectivly. The mean ICSI were (13.6±2.8), (7.7±2.3) and (8.2±2.5) respectivly. The mean ICPI were (10.6±2.6), (7.3±2.1) and (7.7±2.5) respectivly. The mean QOL score were (6.0±0), (2.1±0.5) and (2.7±0.8) respectivly. The mean bladder capacity were (83±27) ml, (234±56) ml and (228±52) ml respectivly. All postoperative indicators showed significant differences compared to the preoperative indicators. ConclusionsCystectasia with sodium hyaluronate balance solution is an effective way in the treatment of ketamine-associated urocystic contracture and the surgery is easy to perform and well tolerated.
Keywords:Ketamine  Urocystic contracture  Cystectasia  Sodium hyaluronate  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华腔镜泌尿外科杂志(电子版)》浏览原始摘要信息
点击此处可从《中华腔镜泌尿外科杂志(电子版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号